Drugs / ONO-4053
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT01909986 | Oct 2013 → Feb 2014 | — | Ono Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT01537172 | Jan → Aug 2012 | — | Ono Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT01379586 | Jun → Jul 2011 | — | Ono Pharmaceutical Co., Ltd. | Terminated | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01748344 | Nov 2012 → Feb 2014 | seasonal allergic rhinitis | Ono Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ONO-4053 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01379586 ↗ |
| Route | Oral | “administered by mouth” NCT01379586 ↗ |